High dietary fructose promotes hepatocellular carcinoma progression by enhancing O-GlcNAcylation via microbiota-derived acetate
Cell Metabolism · 2023-11 · 35 (11) · 1961-1975.e6
DOI: 10.1016/j.cmet.2023.09.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Metabolism, 2023-11. Verfasst von Peng Zhou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Molecular Biology for Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Secon…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 128-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Science Health Joint Medical Scientific Research Project of Chongqing, National Natural Science Foundation of China, Chongqing Medical University.
Abstract (Originalsprache)
Emerging studies have addressed the tumor-promoting role of fructose in different cancers. The effects and pathological mechanisms of high dietary fructose on hepatocellular carcinoma (HCC) remain unclear. Here, we examined the effects of fructose supplementation on HCC progression in wild-type C57BL/6 mice using a spontaneous and chemically induced HCC mouse model. We show that elevated uridine diphospho-N-acetylglucosamine (UDP-GlcNAc) and O-GlcNAcylation levels induced by high dietary fructose contribute to HCC progression. Non-targeted metabolomics and stable isotope tracing revealed that under fructose treatment, microbiota-derived acetate upregulates glutamine and UDP-GlcNAc levels and enhances protein O-GlcNAcylation in HCC. Global profiling of O-GlcNAcylation revealed that hyper-O-GlcNAcylation of eukaryotic elongation factor 1A1 promotes cell proliferation and tumor growth. Targeting glutamate-ammonia ligase or O-linked N-acetylglucosamine transferase (OGT) remarkably impeded HCC progression in mice with high fructose intake. We propose that high dietary fructose promotes HCC progression through microbial acetate-induced hyper-O-GlcNAcylation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Molecular Biology for Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing 400016,…
- Shanghai Applied Protein Technology Co., Ltd., Shanghai 201109, China.
- Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, China.
Förderung
- Science Health Joint Medical Scientific Research Project of Chongqing
- National Natural Science Foundation of China
- Chongqing Medical University
- Higher Education Discipline Innovation Project
- University of Chicago
Zitieren
APA
Zhou, P., Chang, W. Y., Gong, D. A., Xia, J., Chen, W., Huang, L. Y., Liu, R., Liu, Y., Chen, C., Wang, K., Tang, N., & Huang, A. L. (2023). High dietary fructose promotes hepatocellular carcinoma progression by enhancing O-GlcNAcylation via microbiota-derived acetate. Cell Metabolism, 35(11), 1961-1975.e6. https://doi.org/10.1016/j.cmet.2023.09.009
Vancouver
Zhou P, Chang WY, Gong DA, Xia J, Chen W, Huang LY, et al. High dietary fructose promotes hepatocellular carcinoma progression by enhancing O-GlcNAcylation via microbiota-derived acetate. Cell Metabolism. 2023;35(11):1961-1975.e6. doi:10.1016/j.cmet.2023.09.009
BibTeX
@article{Zhou2023,
author = {Zhou, Peng and Chang, Wen-Yi and Gong, De-Ao and Xia, Jie and Chen, Wei and Huang, Lu-Yi and Liu, Rui and Liu, Yi and Chen, Chang and Wang, Kai and Tang, Ni and Huang, Ai-Long},
title = {High dietary fructose promotes hepatocellular carcinoma progression by enhancing O-GlcNAcylation via microbiota-derived acetate},
journal = {Cell Metabolism},
year = {2023},
volume = {35},
number = {11},
pages = {1961--1975.e6},
doi = {10.1016/j.cmet.2023.09.009}
}
EUVIMED